Quoin Net Interest Income from 2010 to 2024

QNRX Stock  USD 0.66  0.07  9.59%   
Quoin Pharmaceuticals Net Interest Income yearly trend continues to be fairly stable with very little volatility. Net Interest Income is likely to outpace its year average in 2024. Net Interest Income is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. View All Fundamentals
 
Net Interest Income  
First Reported
2010-12-31
Previous Quarter
616.7 K
Current Value
647.5 K
Quarterly Volatility
463.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Quoin Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quoin Pharmaceuticals' main balance sheet or income statement drivers, such as Selling General Administrative of 4 M, Total Revenue of 0.0 or Other Operating Expenses of 7 M, as well as many indicators such as Dividend Yield of 7.58, Ptb Ratio of 0.74 or Book Value Per Share of 5.97. Quoin financial statements analysis is a perfect complement when working with Quoin Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Quoin Pharmaceuticals Correlation against competitors.

Latest Quoin Pharmaceuticals' Net Interest Income Growth Pattern

Below is the plot of the Net Interest Income of Quoin Pharmaceuticals Ltd over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Quoin Pharmaceuticals' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quoin Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Interest Income10 Years Trend
Very volatile
   Net Interest Income   
       Timeline  

Quoin Net Interest Income Regression Statistics

Arithmetic Mean(51,105)
Geometric Mean0.00
Coefficient Of Variation(907.21)
Mean Deviation250,871
Median0.00
Standard Deviation463,626
Sample Variance214.9B
Range2M
R-Value(0.02)
Mean Square Error231.4B
R-Squared0.0003
Significance0.96
Slope(1,649)
Total Sum of Squares3T

Quoin Net Interest Income History

2024647.5 K
2023616.7 K
2022-618.3 K
2021-1.4 M
2020-47 K

About Quoin Pharmaceuticals Financial Statements

Quoin Pharmaceuticals investors use historical fundamental indicators, such as Quoin Pharmaceuticals' Net Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quoin Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Interest Income616.7 K647.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quoin Stock Analysis

When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.